Maдопар

Levodopa/Benserazide, the active ingredient in Maдопар, is an antiparkinson agent presented as an oral tablet for oral use. It is employed to manage motor symptoms in patients with Parkinson's disease and related Parkinsonian syndromes by increasing central dopamine levels.

GNH USA supplies Maдопар as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for import and distribution. Customers benefit from reliable lead times, temperature‑controlled logistics where required, and dedicated technical support throughout the procurement process.

Levodopa/Benserazide is used in the management of Parkinsonian disorders by restoring dopamine activity in the central nervous system.

- Parkinson's disease: improves bradykinesia, rigidity and overall motor function in patients. - Parkinsonian syndrome: alleviates motor deficits associated with secondary Parkinsonism. - Resting tremor: reduces amplitude and frequency of tremor episodes. - Motor fluctuations: smooths on‑off periods and enhances daily functional mobility.

Levodopa/Benserazide may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea - Vomiting - Dizziness or light‑headedness - Orthostatic hypotension - Headache - Insomnia

Serious or Rare Side Effects: - Dyskinesia (involuntary movements) - Hallucinations or psychosis - Severe hypotension or syncope - Cardiac arrhythmias - Neuroleptic malignant syndrome - Anaphylactic or severe allergic reactions

When prescribing Levodopa/Benserazide, clinicians should consider several safety measures.

- Dose titration: start low and increase gradually to minimize adverse effects. - Monitor blood pressure: watch for orthostatic hypotension, especially in the elderly. - Assess psychiatric status: be alert for hallucinations or worsening psychosis. - Avoid abrupt discontinuation: sudden stop may exacerbate motor symptoms. - Take with food: meals can reduce gastrointestinal irritation. - Store at ambient temperature: keep in the original pack, protect from moisture.

Levodopa/Benserazide can interact with various medicines, requiring careful management.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Antipsychotics (e.g., haloperidol): may diminish antiparkinson efficacy. - High‑protein meals: decrease levodopa absorption.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive hypotensive effect. - SSRIs or SNRIs: potential for serotonin syndrome. - Iron or calcium supplements: reduce levodopa bioavailability.